Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

VTGNVTGN
Showing 5 of 10 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in VISTAGEN THERAPEUTICS INC

CITADEL ADVISORS LLC holds 68,839 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $15,558 as of 2026-Q2. This is a new position.

Current Value

$15,558

Current Shares

68,839

Total Value Change

-$953,316

Total Shares Change

-253,046

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
68,839
-
$15,5580.0%$0.23
28
2025-Q4
Exited
0
-100.0%
$00.0%$0.68
0
2025-Q3
New
122,062
-
$433,3200.0%$3.54
33
2024-Q4
Exited
0
-100.0%
$00.0%$2.81
0
2024-Q3
Decreased
321,885
-48.9%
$968,8740.0%$3.07
0

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used